Startups
InCephalo
Swiss biotechnology company developing locally delivered treatments for brain cancers and other central nervous system diseases. Its Compartment-Locking platform engineers biologics to remain in the brain compartment and clear rapidly after systemic leakage. Its lead cytokine program targets glioblastoma and remains in development.